Two Sigma Investments »

Acrivon Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $578k 319k 1.81
2025-06-30 $216k 181k 1.19
2022-12-31 $248k 22k 11.52

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Com Cl A (RIVN)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Micron Technology (MU)
Lockheed Martin Corporation (LMT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)

View all positions for Two Sigma Investments

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Citadel Advisors
Wellington Management Company
Vanguard Group
Renaissance Technologies
Acorn Capital Advisors
UBS Group
BlackRock
Two Sigma Investments
Jane Street
Geode Capital Management
Millennium Management
Marshall Wace
Two Sigma Advisers

View all funds holding Acrivon Therapeutics